Henrik Sjövall
University of Gothenburg
113 Papers
728 Citations
Henrik Sjövall is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Fluid transport & Irritable bowel syndrome. The author has an hindex of 34, co-authored 113 publications. Previous affiliations of Henrik Sjövall include Sahlgrenska University Hospital.
Chat about Author
Papers
Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease.
Lena Öhman,Rahil Dahlén,Stefan Isaksson,Åsa Sjöling,Mary Jo Wick,Henrik Sjövall,Lukas Van Oudenhove,Magnus Simren,Hans Strid +8 more
TL;DR: Serum IL-17A levels of treatment-naive patients with UC reflect clinical disease severity at the onset of the disease and also predicted the disease course over the following 3 years, suggesting that serum IL- 17A may be valuable in the clinical management of patients with ULTIMATE ulcerative colitis.
48
Elevated motility‐related transmucosal potential difference in the upper small intestine in the irritable bowel syndrome
Marie H. Larsson,Magnus Simren,Evan A. Thomas,Joel C. Bornstein,Erik Lindström,Henrik Sjövall +5 more
TL;DR: Small intestinal transmural potential difference (PD) is measured on the basis of previous modelling studies to propose that the enhanced secretion may reflect disturbed enteric network behaviour in some patients with IBS.
42
Cholera Toxin Induces Sustained Hyperexcitability in Submucosal Secretomotor Neurons in Guinea Pig Jejunum
TL;DR: This system represents a unique model to understand the neural mechanisms of action of CT and to identify therapeutic targets, and induces specific and sustained hyperexcitability of secretomotor neurons in enteric pathways.
39
Pharmacokinetic study of esomeprazole in patients with hepatic impairment.
Henrik Sjövall,Einar Bjornsson,Johan Holmberg,Göran Hasselgren,Kerstin Röhss,Mohammed Hassan-Alin +5 more
TL;DR: Dose adjustment appears unwarranted in mild or moderate hepatic impairment, but may be required in some severely impaired patients, as esomeprazole was tolerated well across the spectrum of hepatatic impairment.
36
Relationship between interdigestive duodenal motility and fluid transport in humans
TL;DR: The results show that duodenal fluid absorption rate changes markedly during the interdigestive motility cycle, which may be a hydrodnamic phenomenon or may be due to activation of a neural secretory mechanism during phase II.
35